PubMed=7723407
Goto H., Shimazaki C., Tatsumi T., Yamagata N., Fujita N., Tsuchiya M., Koishihara Y., Ohsugi Y., Nakagawa M.
Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism.
Leukemia 9:711-718(1995)

PubMed=8797890; DOI=10.1111/j.1349-7006.1996.tb02108.x; PMCID=PMC5921175
Tatsumi T., Shimazaki C., Goto H., Araki S.-i., Sudo Y., Yamagata N., Ashihara E., Inaba T., Fujita N., Nakagawa M.
Expression of adhesion molecules on myeloma cells.
Jpn. J. Cancer Res. 87:837-842(1996)

DOI=10.1007/0-306-46877-8_4
Jernberg-Wiklund H., Nilsson K.
Multiple myeloma cell lines.
(In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000)

PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2
Drexler H.G., Matsuo Y.
Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.
Leuk. Res. 24:681-703(2000)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)